Portfolio Lab

Hinge Health, Inc.

  • Stock
  • Ticker HNGE
  • NYSE

Technology · Software and IT services · USA

$105.78 −2.15%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Hinge Health, Inc. since 05/2025, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

HNGEGlobal equities (VT)

$10,000 grew to $21,258. Global equities (VT): $10,273.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −48.5% in 02/2026, measured from the peak in 08/2025. It took 10 months to get back to the old peak.

1-year return
+133.2%
Return p.a. since 05/2025
+99.6%
Volatility p.a.
68.1%
Largest decline
−48.5%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue117124139154171182213235
Gross profit9610098126144154184204
Operating income2113-581-6.127324050
EBITDA2214-580-5.828334151
Net income2717-576-1.832354457
Earnings per share2.011.31-13.10-0.022.110.410.520.66
Balance sheet
Total assets673–694770745729827874
Liabilities257–320362366417483575
Equity-435-308174208179112344299
Cash301288237261208187286212
Cash flow
Operating cash flow384.920826443101115
Capital expenditure-0.2-0.1-0.2-0.1-0.4-0.1-0.1-0.4
Free cash flow384.920826343101114

Value it:DCF calculatorMultiples calculator

Annual returns

* partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
9 Nov 2026$0.66
6 Aug 2026$0.52
7 May 2026$0.41
3 Mar 2026$2.11
7 Nov 2025−$0.02
11 Aug 2025−$13.10

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€8.3bn
Market cap in trading currency
$9.15bn
Enterprise value
$8.86bn
P/E
28.6
P/S
11.43
P/B
30.57
EV/Sales
11.06
EV/EBITDA
57.9
Earnings yield
3.5%
FCF yield
3.5%

Results (last four quarters)

Revenue
$801m
Gross profit
$687m
EBITDA
$153m
Net income
$168m
Earnings per share
$3.70
Revenue per share
$9.26
Revenue growth
+52.4%
Earnings growth
–

Profitability

Gross margin
85.7%
Operating margin
18.7%
Net margin
21.0%
Return on equity
66.3%
Return on assets
19.3%

Balance sheet and cash flow

Cash
$295m
Cash per share
$3.41
Financial debt
–
Debt/equity %
–
Current ratio
1.04
Book value per share
$3.46
Operating cash flow
$323m
Free cash flow
$322m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
86.5m
Volume
1.65m
Avg. volume 3 months
1.90m
Relative volume
0.9

Price and technicals

Price
$105.78
1 day
−2.1%
52-week high
$123.23
52-week low
$31.17
Distance to 52-week high
−14.2%
Distance to 52-week low
+239.4%
Distance to 50-day line
−0.3%
Distance to 200-day line
+45.0%
RSI (14)
41
Volatility 1M
49.7%

Performance

1 week
−8.3%
1 month
−3.8%
3 months
+17.6%
6 months
+91.5%
YTD
+127.7%
1 year
+139.9%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has HNGE performed since 05/2025?

$10,000 grew to $28,163 by 20 Nov 2026, which is +99.6% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is HNGE?

Volatility was 68.1% per year, measured on monthly returns. The largest decline from a peak was −48.5%, with the low in 02/2026.

How does HNGE compare with a broad equity ETF?

Over the same period Global equities (VT) returned +12.4% per year at 14.0% volatility, HNGE returned +99.6% at 68.1%. The correlation of monthly returns was 0.31; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Hinge Health, Inc. (HNGE): Return and risk | Portfolio Lab